---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-024725"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:12:38.441814+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma divests Consumer Health business to private e-commerce firm; receives royalty payments

## Summary
- Divested Consumer Health (Innovus Pharmaceuticals) to an undisclosed private e-commerce company after winding down operations.
- Aytu receives revenue-based royalty payments on future sales of former Consumer Health products.
- Company now focuses solely on its prescription pharmaceutical segment to drive profitability.
- Wind down eliminated materially all remaining Consumer Health expenses; near adjusted EBITDA breakeven during wind-down.
- Closure of Grand Prairie, TX manufacturing site expected to further enhance operating margins.

## SEC filing metadata
- accession: 0001437749-24-024725
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000143774924024725/0001437749-24-024725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000143774924024725/aytu20240730_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-024725
- JSON: https://secwatch.observer/filing/0001437749-24-024725.json
- Plain text: https://secwatch.observer/filing/0001437749-24-024725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.